Springer Timothy A

Director, 10% OwnerCartesian Therapeutics, Inc. (RNAC) · full profile →Form 4 · filed Apr 11, 2025
Net Buying
Open-Market Buys
$1.5M
Open-Market Sells
$0
Net Open-Market Flow
$1.5M
Transactions
10
10 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 11, 2025Buy(P)6K$10.77$69K8.6M
Apr 11, 2025Buy(P)36K$10.77$391K657K
Apr 10, 2025Buy(P)3K$10.92$38K620K
Apr 10, 2025Buy(P)45K$10.43$471K617K
Apr 10, 2025Buy(P)609$10.92$7K8.6M
Apr 10, 2025Buy(P)8K$10.43$83K8.6M
Apr 9, 2025Buy(P)7K$9.43$69K8.6M
Apr 9, 2025Buy(P)31$9.95$3088.6M
Apr 9, 2025Buy(P)178$9.95$2K572K
Apr 9, 2025Buy(P)42K$9.43$392K571K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001453687-25-000066) within minutes of acceptance. Every field above traces to the original document. Verify it directly: